BioSpace News Archive

Berkeley Lights, Inc., a leader in cell selection, is currently engaged with universities and medical centers in the U.S., China, and Australia who are looking to create vaccines and therapeutics for the treatment of COVID-19, the disease caused by the SARS-CoV2 virus or, simply, Coronavirus.

The Center for Reproductive Rights, a global human rights organization, today released a powerful video in which its Creative Council and friends raise awareness about the importance of its upcoming U.S. Supreme Court case, June Medical Services v. Russo, which challenges a Louisiana law designed to eliminate access to abortion care and shut down clinics.

At the request of IIROC (“Investment Industry Regulatory Organization of Canada”), Trillium Therapeutics Inc. (the “Company”) (NASDAQ/TSX: TRIL) wishes to confirm that it is not aware of any material, undisclosed information related to the Company that would account for the recent increase in the market price and level of trading volume of its common shares.

NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN : FR0011341205 – the ‘‘Company’’), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced its unaudited annual revenues for Q4 and the unaudited revenues for the year ended December 31, 2019.

Patient-partnered initiative will enable anyone in the USA and Canada affected by osteosarcoma to participate

L2P Research LLC, a leading preclinical CRO, today announced that it had completed its acquisition of METIS Research Laboratories headquartered in Ronkonkoma, New York.

MOUNTAIN VIEW, Calif., Feb. 28, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the fourth quarter and full year of 2019 after the close of trading on Thursday, March 12, 2020. The Company’s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-303

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2019.

With the surging demand for sample collection kits for diagnosing COVID-19 and other upper respiratory tract pathogens, COPAN is concentrating its efforts on strategic items to maximize product output and supply during the ongoing surge in demand due to the novel Coronavirus outbreak.

Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), today announced that on February 28, 2020, it received written notification from the Nasdaq Listing Qualifications Department (“Nasdaq”) for failing to maintain a minimum bid price of U.S.$1.00 per share for the last 30 consecutive business days, as required by Nasdaq Listing Rule 5550(a)(2) – bid price (the “Minimum Bid Price Rule”)